Prathyusha Duraibabu
CIK 1779092 · PRINCIPAL FINANCIAL OFFICER · last filed 2026-02-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$447.2K
Companies
2
Total Filings
42
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ORGO | Director | 247,047 | $1.81 | $447.2K | $0 | 6 | 2026-02-20 |
| SANGAMO THERAPEUTICS, INC (SGMO) Delisted | PRINCIPAL FINANCIAL OFFICER | 660,042 | $0.18 | $117.2K | $0 | 36 | 2026-01-26 |
Recent Filings · Page 4 of 5
42 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-02-17 | ORGO | Grant (A) | +20,547 | $0 | EDGAR |
| 2021-11-23 | ORGO | Grant (A) | +11,340 | $0 | EDGAR |
| 2021-06-14 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Grant (A) | +7,500 | $0 | EDGAR |
| 2021-04-27 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Mixed | +11,887 | -$20.8K | EDGAR |
| 2021-04-27 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Tax (F) | −345 | -$4.2K | EDGAR |
| 2021-04-27 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Tax (F) | −662 | -$7.8K | EDGAR |
| 2021-03-29 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Tax (F) | −345 | -$4.2K | EDGAR |
| 2021-03-01 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Mixed | +11,887 | -$20.8K | EDGAR |
| 2020-04-28 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Tax (F) | −647 | -$5.4K | EDGAR |
| 2020-03-26 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Grant (A) | +3,000 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.